| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $284.2M | -22.5% |
| Cost of Revenue | $227.3M | -24.1% |
| Gross Profit | $56.9M | -15.2% |
| R&D Expense | $6.5M | -24.4% |
| SG&A Expense | $32.1M | -6.7% |
| Operating Income | $11.2M | +47.2% |
| Interest Expense | $1.2M | -64.5% |
| Pre-tax Income | $13.5M | +33.6% |
| Income Tax | $2.8M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.9M | +291.2% |
| Short-term Investments | $50.5M | -35.9% |
| Accounts Receivable | $4.1M | -73.4% |
| Inventory | $30.5M | -31.2% |
| Current Assets | $121.2M | -21.8% |
| Total Assets | $259.9M | -18.3% |
| Current Liabilities | $65.2M | -16.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.6M | +184.8% |
| Capital Expenditures | $9.2M | -43.8% |
| Investing Cash Flow | $46.0M | +2679.0% |
| Financing Cash Flow | -$60.1M | -159.8% |
| Free Cash Flow | $26.4M | +783.1% |
| +100.4% |
| Net Income | $7.0M | -9.7% |
| EPS (Basic) | $0.43 | -6.5% |
| EPS (Diluted) | $0.43 | -6.5% |
| Long-term Debt |
| $49.3M |
| +0.0% |
| Total Liabilities | $76.4M | -43.1% |
| Stockholders' Equity | $183.4M | -0.2% |